-
Something wrong with this record ?
Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels
S. Schedin-Weiss, M. Inoue, L. Hromadkova, Y. Teranishi, NG. Yamamoto, B. Wiehager, N. Bogdanovic, B. Winblad, A. Sandebring-Matton, S. Frykman, LO. Tjernberg,
Language English Country England, Great Britain
Document type Journal Article
NLK
BioMedCentral
from 2009-06-01
BioMedCentral Open Access
from 2009
Directory of Open Access Journals
from 2009
Free Medical Journals
from 2009
PubMed Central
from 2009
Europe PubMed Central
from 2009 to 2020
ProQuest Central
from 2015-01-01
Open Access Digital Library
from 2009-01-01
Open Access Digital Library
from 2009-01-01
Health & Medicine (ProQuest)
from 2015-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2009
Springer Nature OA/Free Journals
from 2009-06-01
- MeSH
- Alzheimer Disease metabolism pathology MeSH
- Amyloid beta-Peptides metabolism MeSH
- Axons metabolism MeSH
- Dendrites metabolism MeSH
- Rats MeSH
- Middle Aged MeSH
- Humans MeSH
- RNA, Small Interfering genetics metabolism MeSH
- Models, Molecular MeSH
- Monoamine Oxidase genetics metabolism MeSH
- Brain metabolism pathology MeSH
- Mice MeSH
- Neurons metabolism ultrastructure MeSH
- Presenilin-1 genetics MeSH
- Receptors, N-Methyl-D-Aspartate metabolism MeSH
- Gene Expression Regulation genetics MeSH
- Amyloid Precursor Protein Secretases metabolism MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Synapses metabolism MeSH
- Transfection MeSH
- Cell Line, Transformed MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Mice MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
BACKGROUND: Increased levels of the pathogenic amyloid β-peptide (Aβ), released from its precursor by the transmembrane protease γ-secretase, are found in Alzheimer disease (AD) brains. Interestingly, monoamine oxidase B (MAO-B) activity is also increased in AD brain, but its role in AD pathogenesis is not known. Recent neuroimaging studies have shown that the increased MAO-B expression in AD brain starts several years before the onset of the disease. Here, we show a potential connection between MAO-B, γ-secretase and Aβ in neurons. METHODS: MAO-B immunohistochemistry was performed on postmortem human brain. Affinity purification of γ-secretase followed by mass spectrometry was used for unbiased identification of γ-secretase-associated proteins. The association of MAO-B with γ-secretase was studied by coimmunoprecipitation from brain homogenate, and by in-situ proximity ligation assay (PLA) in neurons as well as mouse and human brain sections. The effect of MAO-B on Aβ production and Notch processing in cell cultures was analyzed by siRNA silencing or overexpression experiments followed by ELISA, western blot or FRET analysis. Methodology for measuring relative intraneuronal MAO-B and Aβ42 levels in single cells was developed by combining immunocytochemistry and confocal microscopy with quantitative image analysis. RESULTS: Immunohistochemistry revealed MAO-B staining in neurons in the frontal cortex, hippocampus CA1 and entorhinal cortex in postmortem human brain. Interestingly, the neuronal staining intensity was higher in AD brain than in control brain in these regions. Mass spectrometric data from affinity purified γ-secretase suggested that MAO-B is a γ-secretase-associated protein, which was confirmed by immunoprecipitation and PLA, and a neuronal location of the interaction was shown. Strikingly, intraneuronal Aβ42 levels correlated with MAO-B levels, and siRNA silencing of MAO-B resulted in significantly reduced levels of intraneuronal Aβ42. Furthermore, overexpression of MAO-B enhanced Aβ production. CONCLUSIONS: This study shows that MAO-B levels are increased not only in astrocytes but also in pyramidal neurons in AD brain. The study also suggests that MAO-B regulates Aβ production in neurons via γ-secretase and thereby provides a key to understanding the relationship between MAO-B and AD pathogenesis. Potentially, the γ-secretase/MAO-B association may be a target for reducing Aβ levels using protein-protein interaction breakers.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18024770
- 003
- CZ-PrNML
- 005
- 20180712091901.0
- 007
- ta
- 008
- 180709s2017 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s13195-017-0279-1 $2 doi
- 035 __
- $a (PubMed)28764767
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Schedin-Weiss, Sophia $u Karolinska Institutet, Department NVS, Center for Alzheimer Research, Division of Neurogeriatrics, Huddinge, Sweden. sophia.schedin.weiss@ki.se.
- 245 10
- $a Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels / $c S. Schedin-Weiss, M. Inoue, L. Hromadkova, Y. Teranishi, NG. Yamamoto, B. Wiehager, N. Bogdanovic, B. Winblad, A. Sandebring-Matton, S. Frykman, LO. Tjernberg,
- 520 9_
- $a BACKGROUND: Increased levels of the pathogenic amyloid β-peptide (Aβ), released from its precursor by the transmembrane protease γ-secretase, are found in Alzheimer disease (AD) brains. Interestingly, monoamine oxidase B (MAO-B) activity is also increased in AD brain, but its role in AD pathogenesis is not known. Recent neuroimaging studies have shown that the increased MAO-B expression in AD brain starts several years before the onset of the disease. Here, we show a potential connection between MAO-B, γ-secretase and Aβ in neurons. METHODS: MAO-B immunohistochemistry was performed on postmortem human brain. Affinity purification of γ-secretase followed by mass spectrometry was used for unbiased identification of γ-secretase-associated proteins. The association of MAO-B with γ-secretase was studied by coimmunoprecipitation from brain homogenate, and by in-situ proximity ligation assay (PLA) in neurons as well as mouse and human brain sections. The effect of MAO-B on Aβ production and Notch processing in cell cultures was analyzed by siRNA silencing or overexpression experiments followed by ELISA, western blot or FRET analysis. Methodology for measuring relative intraneuronal MAO-B and Aβ42 levels in single cells was developed by combining immunocytochemistry and confocal microscopy with quantitative image analysis. RESULTS: Immunohistochemistry revealed MAO-B staining in neurons in the frontal cortex, hippocampus CA1 and entorhinal cortex in postmortem human brain. Interestingly, the neuronal staining intensity was higher in AD brain than in control brain in these regions. Mass spectrometric data from affinity purified γ-secretase suggested that MAO-B is a γ-secretase-associated protein, which was confirmed by immunoprecipitation and PLA, and a neuronal location of the interaction was shown. Strikingly, intraneuronal Aβ42 levels correlated with MAO-B levels, and siRNA silencing of MAO-B resulted in significantly reduced levels of intraneuronal Aβ42. Furthermore, overexpression of MAO-B enhanced Aβ production. CONCLUSIONS: This study shows that MAO-B levels are increased not only in astrocytes but also in pyramidal neurons in AD brain. The study also suggests that MAO-B regulates Aβ production in neurons via γ-secretase and thereby provides a key to understanding the relationship between MAO-B and AD pathogenesis. Potentially, the γ-secretase/MAO-B association may be a target for reducing Aβ levels using protein-protein interaction breakers.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a Alzheimerova nemoc $x metabolismus $x patologie $7 D000544
- 650 _2
- $a sekretasy $x metabolismus $7 D053829
- 650 _2
- $a amyloidní beta-protein $x metabolismus $7 D016229
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a axony $x metabolismus $7 D001369
- 650 _2
- $a mozek $x metabolismus $x patologie $7 D001921
- 650 _2
- $a transformované buněčné linie $7 D002461
- 650 _2
- $a dendrity $x metabolismus $7 D003712
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a regulace genové exprese $x genetika $7 D005786
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a monoaminoxidasa $x genetika $x metabolismus $7 D008995
- 650 _2
- $a neurony $x metabolismus $x ultrastruktura $7 D009474
- 650 _2
- $a presenilin-1 $x genetika $7 D053764
- 650 _2
- $a malá interferující RNA $x genetika $x metabolismus $7 D034741
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a receptory N-methyl-D-aspartátu $x metabolismus $7 D016194
- 650 _2
- $a synapse $x metabolismus $7 D013569
- 650 _2
- $a transfekce $7 D014162
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Inoue, Mitsuhiro $u Karolinska Institutet, Department NVS, Center for Alzheimer Research, Division of Neurogeriatrics, Huddinge, Sweden. Present address: Dainippon Sumitomo Pharma Co., Ltd, Drug Development Research Laboratories, Osaka, Japan.
- 700 1_
- $a Hromadkova, Lenka $u National Institute of Mental Health, Klecany, Czech Republic. Faculty of Science, Charles University in Prague, Prague, Czech Republic.
- 700 1_
- $a Teranishi, Yasuhiro $u Karolinska Institutet, Department NVS, Center for Alzheimer Research, Division of Neurogeriatrics, Huddinge, Sweden. Present address: Dainippon Sumitomo Pharma Co., Ltd, Drug Development Research Laboratories, Osaka, Japan.
- 700 1_
- $a Yamamoto, Natsuko Goto $u Karolinska Institutet, Department NVS, Center for Alzheimer Research, Division of Neurogeriatrics, Huddinge, Sweden. Present address: Dainippon Sumitomo Pharma Co., Ltd, Drug Development Research Laboratories, Osaka, Japan.
- 700 1_
- $a Wiehager, Birgitta $u Karolinska Institutet, Department NVS, Center for Alzheimer Research, Division of Neurogeriatrics, Huddinge, Sweden.
- 700 1_
- $a Bogdanovic, Nenad $u Department of Geriatric Medicine, University in Oslo, Memory Clinic, Oslo University Hospital, Oslo, Norway.
- 700 1_
- $a Winblad, Bengt $u Karolinska Institutet, Department NVS, Center for Alzheimer Research, Division of Neurogeriatrics, Huddinge, Sweden.
- 700 1_
- $a Sandebring-Matton, Anna $u Karolinska Institutet, Department NVS, Center for Alzheimer Research, Division of Neurogeriatrics, Huddinge, Sweden.
- 700 1_
- $a Frykman, Susanne $u Karolinska Institutet, Department NVS, Center for Alzheimer Research, Division of Neurogeriatrics, Huddinge, Sweden.
- 700 1_
- $a Tjernberg, Lars O $u Karolinska Institutet, Department NVS, Center for Alzheimer Research, Division of Neurogeriatrics, Huddinge, Sweden.
- 773 0_
- $w MED00172451 $t Alzheimer's research & therapy $x 1758-9193 $g Roč. 9, č. 1 (2017), s. 57
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28764767 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180709 $b ABA008
- 991 __
- $a 20180712092154 $b ABA008
- 999 __
- $a ok $b bmc $g 1316901 $s 1021691
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 9 $c 1 $d 57 $e 20170801 $i 1758-9193 $m Alzheimer's research & therapy $n Alzheimers Res Ther $x MED00172451
- LZP __
- $a Pubmed-20180709